These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 11032089)

  • 1. Equivalence concepts in clinical trials.
    Steinijans VW; Neuhäuser M; Bretz F
    Eur J Drug Metab Pharmacokinet; 2000; 25(1):38-40. PubMed ID: 11032089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asthma management: the challenge of equivalence.
    Steinijans VW; Neuhäuser M; Hummel T; Leichtl S; Rathgeb F; Keller A
    Int J Clin Pharmacol Ther; 1998 Mar; 36(3):117-25. PubMed ID: 9562226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A unifying approach to non-inferiority, equivalence and superiority tests via multiple decision processes.
    Hirotsu C
    Pharm Stat; 2007; 6(3):193-203. PubMed ID: 17879327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methodological aspects of superiority, equivalence, and non-inferiority trials.
    Stefanos R; Graziella D'; Giovanni T
    Intern Emerg Med; 2020 Sep; 15(6):1085-1091. PubMed ID: 32705494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific statistical considerations relevant to the design and analysis of gingivitis trials demonstrating product superiority or equivalence.
    Kingman A
    J Periodontal Res; 1992 Jul; 27(4 Pt 2):378-89; discussion 390-4. PubMed ID: 1507027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Methodological and statistical aspects of equivalence and non inferiority trials].
    Elie C; De Rycke Y; Jais JP; Marion-Gallois R; Landais P
    Rev Epidemiol Sante Publique; 2008 Aug; 56(4):267-77. PubMed ID: 18703296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-inferiority versus superiority drug claims: the (not so) subtle distinction.
    Ganju J; Rom D
    Trials; 2017 Jun; 18(1):278. PubMed ID: 28619049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methodology of superiority vs. equivalence trials and non-inferiority trials.
    Christensen E
    J Hepatol; 2007 May; 46(5):947-54. PubMed ID: 17412447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Practical experience with the design and analysis of a three-armed equivalence study.
    Lange S; Freitag G; Trampisch HJ
    Eur J Clin Pharmacol; 1998 Sep; 54(7):535-40. PubMed ID: 9832295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current issues in clinical equivalence trials.
    Blackwelder WC
    J Dent Res; 2004; 83 Spec No C():C113-5. PubMed ID: 15286135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Non-inferiority and equivalence trials: Key methodological issues].
    Herr M; Descatha A; Aegerter P
    Rev Med Interne; 2018 May; 39(5):352-359. PubMed ID: 28693836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statistical vs clinical significance in product testing: can they be designed to satisfy equivalence?
    Kingman A
    J Public Health Dent; 1992; 52(6):353-60. PubMed ID: 1432923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methodological standards in non-inferiority AIDS trials: moving from adherence to compliance.
    Parienti JJ; Verdon R; Massari V
    BMC Med Res Methodol; 2006 Sep; 6():46. PubMed ID: 16987409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple comparisons in non-inferiority trials: Reaction to recent regulatory guidance on multiple endpoints in clinical trials.
    Wiens BL
    J Biopharm Stat; 2018; 28(1):52-62. PubMed ID: 29065276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishing equivalence or non-inferiority in clinical trials: part 20 of a series on evaluation of scientific publications.
    Wellek S; Blettner M
    Dtsch Arztebl Int; 2012 Oct; 109(41):674-9. PubMed ID: 23264808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical trials: active control vs placebo--what is ethical?
    Spławiński J; Kuźniar J
    Sci Eng Ethics; 2004 Jan; 10(1):73-9. PubMed ID: 14986774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating equivalence and noninferiority trials.
    Dasgupta A; Lawson KA; Wilson JP
    Am J Health Syst Pharm; 2010 Aug; 67(16):1337-43. PubMed ID: 20689122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bayes factors for superiority, non-inferiority, and equivalence designs.
    van Ravenzwaaij D; Monden R; Tendeiro JN; Ioannidis JPA
    BMC Med Res Methodol; 2019 Mar; 19(1):71. PubMed ID: 30925900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-inferiority trials: design concepts and issues - the encounters of academic consultants in statistics.
    D'Agostino RB; Massaro JM; Sullivan LM
    Stat Med; 2003 Jan; 22(2):169-86. PubMed ID: 12520555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of putative placebo in active control trials: two applications in a regulatory setting.
    Durrleman S; Chaikin P
    Stat Med; 2003 Mar; 22(6):941-52. PubMed ID: 12627411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.